Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Lymphoma 49Burkitt Lymphoma 33Leukemia 29Lymphoma, Non-Hodgkin 19Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Mantle-Cell 10Leukemia, Biphenotypic, Acute 10Leukemia, Myeloid, Acute 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Large-Cell, Immunoblastic 8Hodgkin Disease 8Myelodysplastic Syndromes 7Lymphoma, Large-Cell, Anaplastic 7Lymphoma, Follicular 7Leukemia, Lymphocytic, Chronic, B-Cell 7Dendritic Cell Sarcoma, Interdigitating 7Leukemia, Myelomonocytic, Chronic 6Multiple Myeloma 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms, Plasma Cell 4Myeloproliferative Disorders 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4HIV Infections 4Blast Crisis 4Acquired Immunodeficiency Syndrome 4Recurrence 3Primary Myelofibrosis 3

Interventions

Cyclophosphamide 5Etoposide 4Cytarabine 3sargramostim 2denileukin diftitox 2Radiotherapy 2Filgrastim 2Dexamethasone 2Carboplatin 2Amifostine 2sodium thiosulfate 1pegfilgrastim 1pegaspargase 1glucarpidase 1etoposide phosphate 1Vincristine 1Silymarin 1Rituximab 1Prednisolone 1Phenobarbital 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Irinotecan 1Ifosfamide 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Fibroblast Growth Factor 7 1Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Leucovorin × Lymphoid × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡